...
首页> 外文期刊>Molecular pharmacology. >State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
【24h】

State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.

机译:雷诺嗪对肌肉Nav1.4和神经元Nav1.7电压门控的Na +通道亚型的状态和使用依赖性阻滞。

获取原文
获取原文并翻译 | 示例
           

摘要

Ranolazine is an antianginal agent that targets a number of ion channels in the heart, including cardiac voltage-gated Na(+) channels. However, ranolazine block of muscle and neuronal Na(+) channel isoforms has not been examined. We compared the state- and use-dependent ranolazine block of Na(+) currents carried by muscle Nav1.4, cardiac Nav1.5, and neuronal Nav1.7 isoforms expressed in human embryonic kidney 293T cells. Resting and inactivated block of Na(+) channels by ranolazine were generally weak, with a 50% inhibitory concentration (IC(50)) >/= 60 microM. Use-dependent block of Na(+) channel isoforms by ranolazine during repetitive pulses (+50 mV/10 ms at 5 Hz) was strong at 100 microM, up to 77% peak current reduction for Nav1.4, 67% for Nav1.5, and 83% for Nav1.7. In addition, we found conspicuous time-dependent block of inactivation-deficient Nav1.4, Nav1.5, and Nav1.7 Na(+) currents by ranolazine with estimated IC(50) values of 2.4, 6.2, and 1.7 microM, respectively. On- and off-rates of ranolazine were 8.2 microM(-1) s(-1) and 22 s(-1), respectively, for Nav1.4 open channels and 7.1 microM(-1) s(-1) and 14 s(-1), respectively, for Nav1.7 counterparts. A F1579K mutation at the local anesthetic receptor of inactivation-deficient Nav1.4 Na(+) channels reduced the potency of ranolazine approximately 17-fold. We conclude that: 1) both muscle and neuronal Na(+) channels are as sensitive to ranolazine block as their cardiac counterparts; 2) at its therapeutic plasma concentrations, ranolazine interacts predominantly with the open but not resting or inactivated Na(+) channels; and 3) ranolazine block of open Na(+) channels is via the conserved local anesthetic receptor albeit with a relatively slow on-rate.
机译:雷诺嗪是一种抗心绞痛药物,其靶向心脏中的许多离子通道,包括心脏电压门控的Na(+)通道。但是,雷诺嗪的肌肉和神经元Na(+)通道亚型的阻滞尚未被检查。我们比较了人类胚胎肾293T细胞中表达的肌肉Nav1.4,心脏Nav1.5和神经元Nav1.7亚型携带的Na(+)电流的状态依赖性和使用依赖性的雷诺嗪阻滞。雷诺嗪的休息和灭活的Na(+)通道阻滞通常较弱,抑制浓度为50%(IC(50))> / = 60 microM。雷诺嗪在重复脉冲期间(5 Hz时+50 mV / 10 ms)的Na(+)通道亚型的使用依赖区阻滞在100 microM时很强,对于Nav1.4峰值电流降低高达77%,对于Nav1峰值电流降低了67%。 5,对于Nav1.7为83%。此外,我们发现灭活缺陷的Nav1.4,Nav1.5和Nav1.7 Na(+)电流的明显时间依赖性阻滞是雷诺嗪的估计IC(50)值分别为2.4、6.2和1.7 microM。 。对于Nav1.4明渠和雷诺嗪的开和关速率分别为8.2 microM(-1)s(-1)和22 s(-1)和7.1 microM(-1)s(-1)和14 Nav1.7对应项分别为s(-1)。 F1579K突变在失活缺陷Nav1.4 Na(+)通道的局麻药受体上降低了雷诺嗪的药效约17倍。我们得出的结论是:1)肌肉和神经元Na(+)通道对雷诺嗪阻滞的敏感性与其心脏对应物相同; 2)在其治疗性血浆浓度下,雷诺嗪主要与开放的Na(+)通道相互作用,但不与静止或灭活的Na(+)通道相互作用;和3)开放的Na(+)通道的雷诺嗪阻滞剂是通过保守的局麻药受体进行的,尽管开通速度相对较慢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号